Medicus Pharma (MDCX) Q1 2026 Annual Earnings
MDCX·Reported May 14, 2026·Before market open
Diluted EPS came in at $-0.31 (+26.2% YoY), missed the $-0.18 consensus by $0.13.
Diluted EPS
$-0.31missed by $0.13
Consensus: $-0.18
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Medicus Pharma's Q1 2026 earnings report.
Medicus Pharma (MDCX) reported Q1 2026 earnings on May 14, 2026 before market open.
Medicus Pharma reported diluted EPS of $-0.31 for Q1 2026.
EPS missed the consensus estimate of $-0.18 by $0.13.
Compared to the same quarter a year prior, diluted EPS grew 26.2% from $-0.42.
You can read the 10-K/A periodic report (0001062993-26-002212) directly on SEC EDGAR. The filing index links above go to sec.gov.